Index by Author

February 2002; 2 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

B

  1. Berkowitz, Barry A.

    • Life Cycle of A Block Buster Drug: Discovery and Development of Omeprazole (PrilosecTM) Mol Interv February 2002 2:6-11; doi:10.1124/mi.2.1.6

C

  1. Carrico, Christine K.

    • The Opium (and Tobacco and Caffeine) of the Masses Mol Interv February 2002 2:59; doi:10.1124/mi.2.1.59

  2. Chen, Y.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

  3. Costa, E.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

D

  1. D'Acquisto, Fulvio

    • Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies Mol Interv February 2002 2:22-35; doi:10.1124/mi.2.1.22

  2. Davis, J.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

  3. Dong, E.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

F

  1. Fishman, Jennifer R.

G

  1. Ghosh, Sankar

    • Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies Mol Interv February 2002 2:22-35; doi:10.1124/mi.2.1.22

  2. Grayson, D.R.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

  3. Griswold, Don E.

  4. Guidotti, A.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

M

  1. May, Michael J.

    • Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies Mol Interv February 2002 2:22-35; doi:10.1124/mi.2.1.22

N

  1. Noh, J.S.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

S

  1. Sachs, George

    • Life Cycle of A Block Buster Drug: Discovery and Development of Omeprazole (PrilosecTM) Mol Interv February 2002 2:6-11; doi:10.1124/mi.2.1.6

  2. Shealy, David

  3. Song, Xiao-yu R.

T

  1. Torphy, Theodore J.

  2. Tremolizzo, L.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

V

  1. Veldic, M.

    • REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome Mol Interv February 2002 2:47-57; doi:10.1124/mi.2.1.47

Current Issue

  1. April 2011, 11 (2)
  1. Current Issue
  1. Alert me to new issues of MI
Society Logo HighWire Press Logo CLOCKSS logo